Business
Faron´s Annual Report 2022 Published
Faron´s Annual Report 2022 Published.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n \n \n \n Faron Pharmaceuticals Oy\n \n \n \n (\"Faron\" or the \"Company\")\n \n \n \n \n \n \n \n \n Faron´s Annual Report 2022 Published \n \n \n \n \n \n \n \n \n \n Company announcement, March 3\n , 2023 at 02:15 AM (EST) / 07:15 AM (GMT) / 09:15 AM (EET)\n \n \n \n \n \n \n \n \n \n TURKU, FINLAND / BOSTON, MA\n \n - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling difficult-to-treat cancers and inflammation via precision immunotherapy, announces today that its Annual Report for the year 2022 and audited financial statements for the accounting period January 1- December 31, 2022 have been published in English, and its financial statements in Finnish.\n \n \n \n \n \n Dr. Markku Jalkanen, Chief Executive Officer, and Toni Hänninen, Chief Financial Officer, will host a virtual briefing and Q&A session for analysts at 7:00 AM (EST) / 12:00 PM (GMT) / 2:00 PM (EET) today. Webcast link\n :\n \n https://faron.videosync.fi/2022-financial-statement\n \n \n \n \n \n \n The full-year results press release for 2022, presentation, virtual briefing webcast details, audited financial statements and Annual Report 2022 is available at\n \n www.faron.com/investors\n \n . A replay of the analyst briefing will be made available shortly afterwards.\n \n \n \n \n \n For more details about the analysts' briefing, please contact\n \n [email protected]\n \n .\n \n \n \n \n \n \n For more information please contact:\n \n \n \n \n \n \n Media Contact\n \n \n \n \n Faron Pharmaceuticals\n \n \n \n Jennifer Smith-Parker\n \n \n Head of Communications\n \n \n \n [email protected]\n \n \n \n \n \n \n \n Cairn Financial Advisers LLP, Nomad\n \n \n \n Sandy Jamieson, Jo Turner\n \n \n Phone: +44 (0) 207 213 0880\n \n \n \n \n \n \n \n \n Peel Hunt LLP, Broker\n \n \n \n Christopher Golden, James Steel\n \n \n Phone: +44 (0) 20 7418 8900\n \n \n \n \n \n \n \n \n Sisu Partners Oy, Certified Adviser on Nasdaq First North\n \n \n \n Juha Karttunen\n \n \n Phone: +358 (0)40 555 4727\n \n \n Jukka Järvelä\n \n \n Phone: +358 (0)50 553 8990\n \n \n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n David Daley, Lindsey Neville, Namrata Taak\n \n \n \n [email protected]\n ...